No, insurance does not cover BPC-157. As a compounded peptide, it falls outside standard pharmacy benefit coverage entirely, and no insurer, including Medicare or Medicaid, pays for it. The realistic path is cash-pay treatment at a stated monthly price, with FSA or HSA funds often available to help.
No insurance plan covers BPC-157. It is a compounded peptide, not an FDA-approved drug with a formulary tier, so standard pharmacy coverage does not apply. TelosRX offers it as a cash-pay treatment as low as $116 a month, and it is FSA and HSA eligible.
Start your intake →Why insurance will not cover BPC-157
BPC-157 is a compounded peptide, prepared by licensed compounding pharmacies rather than manufactured as an FDA-approved drug. Insurance formularies are built around approved medications with an assigned billing code, and compounded peptides sit outside that structure entirely.
This is not a matter of the wrong paperwork or a missing prior authorization. There is no formulary tier for BPC-157 to sit on in the first place, so there is nothing to appeal your way into. That distinction matters, and it is worth being direct about rather than leaving it vague.
Some people search for this expecting a workaround, a specific code, or a plan that quietly covers it. There is not one. Being upfront about that now saves time you would otherwise spend chasing a dead end.
What BPC-157 actually is
BPC-157 is a peptide most often discussed in the context of recovery and general wellness support. Because it is compounded rather than manufactured as an FDA-approved product, it is not FDA-approved in the form telos rx dispenses it.
Any prescription is subject to medical approval by a licensed provider, based on the intake you complete and your specific health history. You can review current details on the BPC-157 product page before starting an intake.
Key takeaway: No insurer covers BPC-157, and that is unlikely to change soon given how formularies are structured. Cash-pay access at a stated price is the option that actually exists today.
Why this applies to peptide therapy broadly
BPC-157 is not an isolated exception. Compounded peptide therapy as a category, including PT-141, sermorelin, and NAD+ nasal spray, sits outside standard insurance coverage for the same structural reason. None of these carries an FDA approval in the compounded form offered here.
Insurers build their systems around approved products with defined indications. A compounded peptide, regardless of how it is discussed elsewhere, does not fit into that system, and no amount of documentation changes that basic fact.
This holds true whether the plan is a large employer plan, a marketplace plan, or a government program. The category itself, not any particular plan's generosity, is what determines the outcome here.
What people usually mean when they ask about coverage
When people search for whether insurance covers BPC-157, they are often really asking one of two different questions. Some want to know if there is any way to get a plan to pay. Others simply want an honest price they can plan around once they accept that insurance is not involved.
This article is written for both. The answer to the first question is no, without meaningful exception. The answer to the second is a stated monthly price with no hidden steps, which is what a cash-pay model is built to provide.
What cash-pay treatment actually costs
BPC-157 through telos rx starts as low as $116 a month, billed transparently with no hidden add-ons after the fact. That price includes the full compounded prescription, prepared by a partner compounding pharmacy once a licensed provider approves your intake.
Because there is no insurance claim involved, there is also no surprise bill weeks later reflecting a denied claim or an unexpected copay adjustment. The price you see reflects what you actually pay.
See if BPC-157 fits your situation and review current pricing before committing to anything.
Using FSA or HSA funds for BPC-157
Even though insurance does not cover BPC-157, your FSA or HSA may still apply, since these accounts follow IRS rules about qualified medical expenses rather than insurance formulary rules. TelosRX plans are FSA and HSA eligible, meaning pretax dollars can typically be applied to the monthly cost.
This distinction genuinely matters. A treatment can sit completely outside insurance while still qualifying for pretax spending, and BPC-157 through telos rx generally falls into that category. Confirm your specific administrator's documentation rules before assuming eligibility, since requirements differ by employer and plan, and some administrators ask for a letter of medical necessity before releasing funds.
How intake and approval actually work
There is no referral and no prior authorization request involved, since this is a cash-pay pathway rather than an insurance claim. You complete an asynchronous online visit describing your health history and goals, and a licensed provider reviews it on their own schedule rather than a booked appointment slot.
Approval is never automatic and is not guaranteed for anyone. It depends on a licensed provider's review of your specific history, and some intakes are not approved. If approved, a partner compounding pharmacy fills the prescription and ships it directly to you.
Most people finish intake in a matter of minutes and receive a decision quickly, since asynchronous review removes the wait for a scheduled visit.
Why your regular doctor may not offer this
If your primary care provider has not discussed BPC-157 with you, that is usually about scope of practice rather than doubt about your interest. Compounded peptide therapy is a specialized area that many general practices simply do not carry as part of their standard offerings.
A telehealth provider focused specifically on compounded peptide therapy, as telos rx providers are, is generally better positioned to evaluate a request like this. That reflects a difference in clinical focus, not a shortcut around any insurance requirement.
It also is not a signal that anything about your interest is inappropriate. Many well-qualified people simply see a provider whose practice does not typically handle this specific category, and a specialized review exists to close exactly that gap.
What to expect if you are approved
Once approved, your plan generally includes ongoing access to your provider for questions about dosing or how you are responding to treatment. Compounded peptide protocols are typically reviewed periodically rather than treated as a one-time prescription.
Be thorough and honest about your full medical history during intake, including any current medications or existing conditions. That information gives your provider the complete picture needed to make an appropriate decision, and leaving details out only slows things down with follow-up questions later.
How BPC-157 compares to other recovery-focused options
People researching BPC-157 sometimes come from trying oral supplements, physical therapy, or other recovery-focused routines first. Those approaches are not mutually exclusive with a compounded peptide protocol, and many people continue them alongside treatment rather than replacing one with the other.
What sets a compounded peptide apart from an over-the-counter supplement is the oversight built into the process. A licensed provider reviews your history before approving anything, rather than a product simply being available for anyone to purchase without any clinical review at all.
That oversight is also why pricing looks the way it does. You are paying for a reviewed prescription prepared by a licensed compounding pharmacy, not a mass-market product sitting on a shelf.
Setting realistic expectations
Individual results vary, and no responsible source should promise a specific outcome or timeline before your provider has even reviewed your history. What a provider can tell you is how the protocol is generally structured and what a typical course of treatment involves.
Ask your provider directly about what to expect during your specific course of treatment, rather than relying on anecdotes from people whose health history differs from yours. Your intake and any follow-up messaging exist for exactly this kind of question, and asking early is always better than guessing on your own and adjusting anything without your provider's input.
Start your intake to get guidance specific to your own history rather than a generic timeline.
Frequently Asked Questions
Does any insurance plan cover BPC-157?
No. BPC-157 is a compounded peptide without an FDA approval in this form, so it does not carry standard insurance, Medicare, or Medicaid coverage. Cash-pay access is the option that actually exists.
Is BPC-157 FDA-approved?
No. The compounded version telos rx dispenses is not FDA-approved. It is prepared by a licensed compounding pharmacy under separate compounding regulations.
Can I use FSA or HSA funds for BPC-157?
Yes, telos rx plans are FSA and HSA eligible, so pretax dollars can typically be applied toward the monthly cost. Check your specific plan's documentation rules with your administrator first.
How much does BPC-157 cost through telos rx?
Pricing starts as low as $116 a month on a transparent basis. Your exact cost depends on your provider's recommendation after intake and approval.
Why has my regular doctor never mentioned BPC-157?
Compounded peptide therapy is a specialized area many primary care practices do not carry. A telehealth provider focused on this category is often better positioned to evaluate whether it fits your history.
Is a prescription guaranteed after intake?
No. Every prescription is subject to medical approval by a licensed provider based on your health history. Some intakes are not approved, and that decision rests with the reviewing provider.
TelosRX is LegitScript-certified. Compounded medication is not FDA-approved and is prepared under federal compounding regulations. This article is general information, not medical advice, and does not replace guidance from your own provider. Approval is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service. For general background on unregulated and compounded substances, see the NIH NCCIH overview of dietary and herbal supplements. For how compounded medication is regulated, see the FDA overview of drug compounding.
Questions about pricing or eligibility? Message the TelosRX care team or start your evaluation at TelosRX.